Orifarm GmbH

DER3306.HRB49442|Fixheider Straße 4, 51381 LeverkusenGermany|1998

Profit€9.9M

Revenue€582.6M

Employees167

Balance€140.2M

About

Die Orifarm GmbH ist im Bereich des Re- und Parallelimports von Arzneimitteln tätig und vertreibt diese primär an Großhändler und Apotheken in Deutschland.

Business purpose (commercial register)

Gegenstand des Unternehmens ist der Vertrieb von pharmazeutischen Erzeugnissen.

ClassificationWZ 2025

G.47.73.0 - Einzelhandel mit pharmazeutischen Erzeugnissen

Products

Arzneimittel

Opportunities & Risks

Wachstum Marktanteilsgewinn Vertrieb Produkteinführung Lieferengpässe

Regulierung Politische Abhängigkeiten Lieferverträge Preisdruck Wettbewerbsdruck Währungsrisiken

This summary was generated with the help of AI. See our Data Quality Notice. Report error?

Source: German Commercial Register (Handelsregister) Köln Local Court, HRB 49442 (as of 8 October 2026)

Company Structure

Shareholders

Name	Type	City
Thomas Brandhof	Geschäftsführer(in)	Odense M

Source: German Commercial Register (Handelsregister) Köln Local Court, HRB 49442 (as of 8 October 2026)

Company History

Management

CPV categories

Pharmaceutical products

Date	Contract	Role	Counterparty	Value
17.9.2026	Arzneimittelvergaben Blutprodukte zum 01.01.2027 Supplier · PBMG eG	Supplier	PBMG eG	—
24.6.2026	Arzneimittelvergaben zum 01.01.2026 und 01.07.2026 Supplier · PBMG eG	Supplier	PBMG eG	—
13.5.2026	Arzneimittelvergaben zum 01.07.2026 Supplier · PBMG eG	Supplier	PBMG eG	—

Financials

Key financial figures over time — Orifarm GmbH
Year	Revenue	Profit	Balance	Employees
2024	€582,571,282	€9,882,315	€140,198,941	—
2023	€403,713,156	€7,451,622	€126,493,201	167
2022	€367,052,077	€3,852,778	€117,123,301	152
2021	€344,062,684	€3,161,197	€48,647,736	148
2020	€340,314,963	€3,076,707	€59,441,683	143
2019	€330,324,756	€2,424,563	€56,485,913	128
2018	€282,415,117	€2,458,876	€48,486,640	119
2017	€279,728,740	€2,490,681	€52,832,236	—
2016	€277,798,772	€4,095,683	€48,954,004	—
2015	€363,063,386	€0	€41,957,024	—

Source: German Company Register (Unternehmensregister)

Register Files

Current Printout (AD)

Chronological Printout (CD)

List of Shareholders

Articles of Association

Registration Application

Source: German Commercial Register (Handelsregister) Köln Local Court, HRB 49442 (as of 8 October 2026)

Contact

Website:orifarm.com

Email:Sign in to view

USt-IdNr.:DE190719633

Similar Companies

kohlpharma GmbH

Merzig · Einzelhandel mit pharmazeutischen Erzeugnissen

Teleflex Medical GmbH

Fellbach · Einzelhandel mit pharmazeutischen Erzeugnissen

€136.8M

betapharm Arzneimittel GmbH

Augsburg · Einzelhandel mit pharmazeutischen Erzeugnissen

€151.5M

Annual Financial Statements

Annual Report 2024Published on 13 February 2026

Annual Report 2023Published on 2 May 2025

Annual Report 2022Published on 17 April 2024

Annual Report 2021Published on 25 May 2023

Annual Report 2020Published on 16 May 2022

Annual Report 2019Published on 3 March 2021

Annual Report 2018Published on 8 June 2020

Annual Report 2017Published on 9 May 2019

Annual Report 2016Published on 19 March 2018

Annual Report 2015Published on 20 March 2017

Annual Report 2014Published on 7 April 2016

Annual Report 2013Published on 16 April 2015

Annual Report 2012Published on 10 April 2014

Annual Report 2011Published on 27 May 2013

Annual Report 2010Published on 9 July 2012

Annual Report 2009Published on 9 May 2011

Annual Report 2008Published on 11 March 2010

Annual Report 2007Published on 9 March 2009

Annual Report 2006Published on 21 April 2008

Source: German Company Register (Unternehmensregister)

Cost type	Amount	Share
Personnel Costs	€13,802,858	86.6%
Depreciation	€1,207,955	7.6%
Interest & Similar	€934,755	5.9%

Orifarm GmbH

About

Business purpose (commercial register)

ClassificationWZ 2025

Products

Opportunities & Risks

Company Structure

Company History

Financials

Register Files

Contact

Similar Companies

Annual Financial Statements

Cost Distribution (2024)

Trends